22 Sept 2021 Jahr - FDA authorizes Pfizer booster dose for certain populations.

Beschreibung:

Via the FDA, Pfizer booster doses were authorized for these populations:
- individuals 65 years of age and older;
- individuals 18 through 64 years of age at high risk of severe COVID-19; and
- individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19.

https://www.fda.gov/news-events/press-announcements/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations

Zugefügt zum Band der Zeit:

Datum: